XNASBON
Market cap6mUSD
Dec 24, Last price
1.53USD
1D
2.71%
1Q
-12.57%
IPO
-97.96%
Name
Bon Natural Life Ltd
Chart & Performance
P/E
1.32
P/S
0.21
EPS
1.16
Div Yield, %
0.00%
Shrs. gr., 5y
3.35%
Rev. gr., 5y
22.32%
Revenues
30m
-1.29%
Net income
5m
-26.32%
CFO
-652k
L+248.39%
Profile
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The company provides personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; natural health supplements comprising powder drinks and bioactive food ingredient products primarily used as food additives; and nutritional supplements. Its products are principally used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is headquartered in Grand Cayman, the Cayman Islands.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | |
| Income | ||||||
Revenues | 29,522 -1.29% | 29,909 17.31% | ||||
Cost of revenue | 23,604 | 23,368 | ||||
Unusual Expense (Income) | ||||||
NOPBT | 5,919 | 6,540 | ||||
NOPBT Margin | 20.05% | 21.87% | ||||
Operating Taxes | 1,002 | 1,267 | ||||
Tax Rate | 16.93% | 19.37% | ||||
NOPAT | 4,916 | 5,273 | ||||
Net income | 4,596 -26.32% | 6,237 35.87% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 2,028 | |||||
BB yield | -54.70% | |||||
| Debt | ||||||
Debt current | 3,240 | 4,890 | ||||
Long-term debt | 1,282 | 1,101 | ||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | 4,409 | (17,388) | ||||
| Cash flow | ||||||
Cash from operating activities | (652) | (187) | ||||
CAPEX | (522) | (4,736) | ||||
Cash from investing activities | (1,186) | (3,056) | ||||
Cash from financing activities | 1,155 | 2,262 | ||||
FCF | (7,680) | 1,632 | ||||
| Balance | ||||||
Cash | 113 | 841 | ||||
Long term investments | 22,537 | |||||
Excess cash | 21,883 | |||||
Stockholders' equity | 17,894 | 14,381 | ||||
Invested Capital | 40,185 | 19,879 | ||||
ROIC | 16.37% | 31.55% | ||||
ROCE | 14.73% | 19.09% | ||||
| EV | ||||||
Common stock shares outstanding | 920 | 8,396 | ||||
Price | 4.03 -81.36% | 21.63 -74.47% | ||||
Market cap | 3,707 -97.96% | 181,565 -68.04% | ||||
EV | 8,613 | 164,708 | ||||
EBITDA | 7,102 | 6,910 | ||||
EV/EBITDA | 1.21 | 23.84 | ||||
Interest | 238 | 447 | ||||
Interest/NOPBT | 4.02% | 6.83% | ||||